S.Biomedics Co., Ltd. · 전환사채(해외전환사채포함)발행후만기전사채취득 (제5회차)
Acquisition of Convertible Bonds (Incl. Overseas CBs) Before Maturity
| Convertible bonds (overseas CBs) | 5 | Series No. |
| 1. Bonds Acquired Before Maturity | Type of Bonds | Bearer Coupon Unsecured Private Convertible Bonds |
| Issue date | 2024-11-13 | |
| Issuance method | Domestic issuance (private) | |
| Conversion price per share (KRW) | 23,065 | |
| Maturity Date | 2029-11-13 | |
| 2. Bond Acquisition Amount (Currency) | 309,118,800 | KRW : South-Korean Won |
| - Total Face (Electronically Registered) Value of Bonds Acquired (Currency) | 300,000,000 | KRW : South-Korean Won |
| - Base Exchange Rate | - | |
| - Acquisition Date | 2026-11-13 | |
| 3. Total Face (Electronically Registered) Value of Bonds After Acquisition (Currency) | 945,000,000 | KRW : South-Korean Won |
| 4. Reason for Pre-Maturity Acquisition and Planned Treatment | - 취득사유: 사채권자의 조기상환청구권(풋옵션) 행사 - 향후 처리방법: 향후 재매각 또는 소각 결정 | |
| 5. Source of Acquisition Funds | Own Funds | |
| 6. Bond Acquisition Method | Off-Market Purchase | |
| 7. Other Matters Relevant to Investment Decisions | - 상기 '주당 전환가액'은 2026.08.13 조정된 전환가액입니다. - 상기 '취득일자'는 사채 취득금액 지급일입니다. | |
| ※ Related Disclosures | 2024-11-13 전환사채권발행결정(제5회차) 2024-11-13 증권 발행결과(자율공시)(제5회차 CB) 2025-06-13 전환가액의조정(제5회차) 2026-01-14 전환가액의조정(제5회차) 2026-08-13 전환사채(해외전환사채포함)발행후만기전사채취득(제5회차) 2026-08-13 전환가액의조정(제5회차) | |